Clinical Trial Update: Serum Anti-PCOLCE as Novel Diagnostic Biomarker in Rheumatoid Arthritis With Emphasis on Seronegative Patients.

View source ↗

Summary

This clinical trial update describes Serum Anti-PCOLCE as a potential diagnostic biomarker for rheumatoid arthritis, with emphasis on seronegative patients, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Assiut University | Conditions: Rheumatoid Arthritis | Status: NOT_YET_RECRUITING